Endovascular Technologies for Emergency Situations
Company Founded Year
Company Number of Employees
Amnis Therapeutics is a biomedical engineering company specializing in developing, manufacturing, and marketing lifesaving endovascular technologies for emergency situations. Its mission is to provide the medical community with innovative, high-performance devices that offer a reliable, proven solution for numerous endovascular indications.
The companyâ€™s AneugraftDx is a pericardium covered coronary stent for emergency vessel reconstruction in cases of acute rupture or dissection of a coronary artery, coronary aneurysm, or saphenous vein graft reperfusion.
The AneugraftNx is a neurovascular pericardium covered stent designed specifically for intracranial indications such as aneurysms, ruptures, and cavernous carotid fistulas (CCFs). The innovative, biologically covered stents provide immediate blood vessel reconstruction in a one-step procedure.
In addition to its covered stent technology, Amnis Therapeutics is expanding its product development to include other unique solutions for emergency intra-arterial interventions. The most recent of these products is the Golden Retriever, a mechanical neurothrombectomy device for the emergency treatment of acute ischemic stroke.